Mead Johnson (MJN) Tops Q2 EPS by 10c, Sales Miss; Reaffirms EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
BMO Capital Remains Bullish on Mead Johnson (MJN) Following 2Q Report
July 29, 2016 9:22 AM EDTBMO Capital reiterated an Outperform rating with a $97.00 price target on Mead Johnson Nutrition (NYSE: MJN) following the company's 2Q earnings report. MJN reported EPS of $0.88, above $0.81 estimates. The company reiterated EPS guidance of $3.48-3.60.
Analyst Amit Sharma commented, "MJN reported 2Q16 adjusted EPS of $0.88,... More
Societe Generale Downgrades Mead Johnson Nutrition (MJN) to Hold
July 29, 2016 6:52 AM EDTSociete Generale downgraded Mead Johnson Nutrition (NYSE: MJN) from Buy to Hold with a price target of $95.00 (from $100.00).
For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.
Shares of Mead Johnson Nutrition closed at $89.89 yesterday.
... More